Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils

Journal of Periodontal Research

Volumn 47, Issue 5, 2012, Pages 554-562

  Hiroshima, Y ^a   Bando, M ^a   Inagaki, Y ^a   Mihara, C ^a   Kataoka, M ^b   Murata, H ^a   Shinohara, Y ^a   Nagata, T ^a   Kido, J ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Gingival crevicular fluid; Neutrophil; Periodontitis; Resistin

Indexed keywords

ACTIN CAPPING PROTEIN; COLCHICINE; CYTOCHALASIN B; CYTOCHALASIN D; GLYCOSYLATED HEMOGLOBIN; LIPOPOLYSACCHARIDE; NOCODAZOLE; NUCLEIC ACID SYNTHESIS INHIBITOR; RESISTIN; RETN PROTEIN, HUMAN; TUBULIN MODULATOR;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CULTURE TECHNIQUE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PERIODONTAL POCKET; PERIODONTICS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SECRETION (PROCESS);

ACTIN CAPPING PROTEINS; ADULT; AGED; CELL CULTURE TECHNIQUES; CHRONIC PERIODONTITIS; COLCHICINE; CYTOCHALASIN B; CYTOCHALASIN D; DIABETES COMPLICATIONS; FEMALE; GINGIVAL CREVICULAR FLUID; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; NOCODAZOLE; NUCLEIC ACID SYNTHESIS INHIBITORS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RESISTIN; TUBULIN MODULATORS;

EID: 84865553635     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01466.x     Document Type: Article

References (58)

1. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
2. Steppan CM, Brown EJ, Wright CM et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001;98:502-506.
3. Filková M, Haluzík M, Gay S, Šenolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 2009;133:157-170.
4. Kunnari AM, Savolainen ER, Ukkola OH, Kesäniemi YA, Jokela MA. The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFα. Regul Pept 2009;157:57-63.
5. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
6. Schäffler A, Ehling A, Neumann E et al. Adipocytokines in synovial fluid. JAMA 2003;290:1709-1710.
7. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003;88:5452-5455.
8. Heilbronn LK, Rood J, Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004;89:1844-1848.
9. Youn BS, Yu KY, Park HJ et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:150-156.
10. Osawa H, Onuma H, Murakami A et al. Systematic search for single nucleotide polymorphisms in the resistin gene. Diabetes 2002;51:863-866.
11. Osawa H, Yamada K, Onuma H et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 2004;75:678-686.
12. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329-334.
13. Southerland JH, Taylor GW, Moss K, Beck JD, Offenbacher S. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol 2000 2006;40:130-143.
14. Saito T, Yamaguchi N, Shimazaki Y et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res 2008;87:319-322.
15. Furugen R, Hayashida H, Yamaguchi N et al. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodont Res 2008;43:556-562.
16. Andrian E, Grenier D, Rouabhia M. Porphyromonas gingivalis-epithelial cell interactions in periodontitis. J Dent Res 2006;85:392-403.
17. Yamaji Y, Kubota T, Sasaguri K et al. Inflammatory cytokine gene expression in human periodontal ligament fibroblasts stimulated with bacterial lipopolysaccharides. Infect Immun 1995;63:3576-3581.
18. Koide M, Kinugawa S, Takahashi N, Udagawa N. Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 2010;54:235-246.
19. Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1β, TNF-α, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontophathic bacteria. J Periodont Res 1997;32:279-286.
20. Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14 - Toll-like receptor-nuclear factor κB pathway. J Periodont Res 2003;38:557-563.
21. Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. Oral Microbiol Immunol 2004;19:182-187.
22. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002;530:158-162.
23. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004;1:e45.
24. Anderson PD, Mehta NN, Wolfe ML et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007;92:2272-2279.
25. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:532-551.
26. Kido J, Nakamura T, Kido R et al. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J Clin Periodontol 1999;26:653-657.
27. Nakamura T, Kido J, Kido R et al. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol 2000;71:361-367.
28. Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res 1997;32:524-529.
29. Darveau RP, Pham TT, Lemley K et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72:5041-5051.
30. Yoshimura A, Kaneko T, Kato Y et al. Lipopolysaccarides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun 2002;70:218-225.
31. Bulkacz J, Carranza FA. Defense mechanisms of the gingival. In: Newman MG, Takei HH, Carranza FA, eds. Carranza's Clinical Periodontology 9th edn. Philadelphia: WB Saunders, 2002:254-257.
32. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta 2004;343:1-16.
33. Taba M Jr, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 2005;49:551-571.
34. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Sallam R. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Diabetes Metab Res Rev 2008;24:52-58.
35. Osawa H, Doi Y, Makino H, Tanizaki T, Iida M, Kiyohara Y. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama study. Cardiovasc Diabetol 2009;8:60-68.
36. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789-5795.
37. Presle N, Pottie P, Dumond H et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthr Cartil 2006;14:690-695.
38. Fagerhol MK, Andersson KB, Naess-Andresen C, Dale I. Calprotectin (The L1 leukocyte protein). In: Smith VL, Dedman JR, eds. Stimulus Response Coupling: The Role of Intracellular Calcium-binding Proteins. Boca Raton, FL, USA: CRC Press, 1990:187-210.
39. Ikezawa-Suzuki I, Shimada Y, Tai H, Komatsu Y, Tanaka A, Yoshie H. Effects of treatment on soluble tumor necrosis factor receptor type 1 and 2 in chronic periodontitis. J Clin Periodontol 2008;35:961-968.
40. Mcternan PG, Fisher FM, Valsamakis G et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003;88:6098-6106.
41. Hasegawa G, Ohta M, Ichida Y et al. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 2005;42:104-109.
42. Kunnari A, Ukkola O, Päivänsalo M, Kesäniemi YA. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 2006;91:2755-2760.
43. Dullaart RPF, de Vries R, Sluiter WJ, Voorbij HAM. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clin Endocrinol 2009;70:221-226.
44. Fargnoli JL, Sun Q, Olenczuk D et al. Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 2010;162:281-288.
45. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005;111:932-939.
46. d'Elia HF, Pullerits R, Carlsten H, Bokarewa M. Resisitin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology 2008;47:1082-1087.
47. Onuma H, Tabara Y, Kawamura R et al. A at single nucleotide polymorphism -358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population. PLoS One 2010;5:e9718.
48. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem Biophys Res Commun 2005;334:1092-1101.
49. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003;309:286-290.
50. Kopp A, Buechler C, Neumeier M et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity 2009;17:648-656.
51. Johansson L, Linnér A, Sundén-Cullberg J et al. Neutrophil-derived hyperresistinemia in severe acute Streptococcal infections. J Immunol 2009;183:4047-4054.
52. Boström EA, Tarkowski A, Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta 2009;1793:1894-1900.
53. Brown SS, Spudich JA. Cytochalasin inhibits the rate of elongation of actin filament fragments. J Cell Biol 1979;83:657-662.
54. Isowa N, Liu M. Role of LPS-induced microfilament depolymerization in MIP-2 production from rat pneumocytes. Am J Physiol Lung Cell Mol Physiol 2001;280:L762-L770.
55. Segawa A, Yamashina S. Roles of microfilaments in exocytosis: a new hypothesis. Cell Struct Funct 1989;14:531-544.
56. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008;14:741-751.
57. Cohen G, Ilic D, Raupachova J, Hörl WH. Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol 2008;181:3761-3768.
58. Thommesen L, Stunes AK, Monjo M et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006;99:824-834.